Symbicort (budesonide/formoterol) will be used more for COPD
Symbicort (budesonide/formoterol) will be used more for COPD.
It's now the second corticosteroid/beta-agonist combo approved for maintenance of COPD...along with Advair (fluticasone/salmeterol).
But these are NOT first-line therapies.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 300+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote